Lv01
0 积分 2025-04-13 加入
SsrA-based design of BacPROTACs for β-lactamase degradation in Gram-negative bacteria
3分钟前
已完结
Dysregulation of bacterial proteolytic machinery by a new class of antibiotics
7分钟前
已完结
A Pt (IV)/losartan/immunotherapy Co-delivery thermosensitive gel synergizes STING activation and cancer-associated fibroblast inhibition for ovarian cancer chemoimmunotherapy
2个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
3个月前
已完结
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
3个月前
已完结
Insights Into Vepdegestrant (ARV‐471): The First‐in‐Class Estrogen Receptor Proteolysis‐Targeting Chimera Approaching Food and Drug Administration Approval for Breast Cancer
3个月前
已完结
Structural and Physicochemical Features of Oral PROTACs
3个月前
已完结
Development of Telmisartan Platinum(IV) Complexes for Antimetastatic Therapy: Targeting EMT and Tumor Immunity through Suppressing AT1R
3个月前
已完结
Discovery of a Potent, Selective and In Vivo Active Aurora A PROTAC Degrader from a Promiscuous Kinase Inhibitor
4个月前
已完结